 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Dec 31, 2011 |
| Title |
Comparison of post-mortem tissue from Brodman Brain BA22 region between schizophrenic and control patients |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
Transcriptional analysis of the superior temporal cortex (BA22) in schizophrenia: Pathway insight into disease pathology and drug development
Schizophrenia is a highly debilitating psychiatric disorder which is known to have heritable genetic and environmental components. To gain some insight into the mechanisms underpinning both positive and negative symptoms of the disease, we determined the genome wide expression of mRNA transcripts in post-mortem tissue from the superior temporal cortex (Brodmann Area 22, BA22) in schizophrenic and control patients. The BA22 region is known to mediate the positive pathophysiology of schizophrenia; we compared this to the anterior prefrontal cortex (BA10) from the same subjects, which is known to mediate negative symptoms. Following adjustments for confounding clinical, sample and experimental sources of variation, we carried out gene set enrichment analysis in each region using pathway data. We identified an over-representation of genes involved in cytoskeletal remodelling, neurodevelopment, cell adhesion, cellular signalling, neurotransmission and autophagy. Collectively our analysis indicates a disruption of processes underpinning synaptic plasticity in both regions. Region-specific changes support the dysregulation of distinct pathways in the BA10 and BA22 regions. This may highlight new therapeutic opportunities to treat both negative and positive symptoms of the disease.
|
| |
|
| Overall design |
Post-mortem derived BA22 tissue from schizophrenic and control patients were compared. Age, gender, post-mortem delay and pH of brain lysates data were also captured.
|
| |
|
| Contributor(s) |
Barnes MR, Huxley-Jones J, Maycox P, Lennon M, Molesworth AM, Kelly F, Bates S, Taylor A, Reid J, Jones N, Schroeder J, Scorer C, Davies C, Hagan JJ, Kew JN, Angelinetta C, Akbar TM, Hirsch S, Mortimer AM, Barnes TR, deBelleroche J |
| Citation(s) |
21538462 |
| |
| Submission date |
May 20, 2010 |
| Last update date |
Mar 25, 2019 |
| Contact name |
Julie Huxley-Jones |
| E-mail(s) |
julie.x.huxley-jones@gsk.com
|
| Phone |
01438 768416
|
| Organization name |
GlaxoSmithKline Pharmaceuticals
|
| Department |
Computational Biology
|
| Street address |
Gunnels Wood Road
|
| City |
Stevenage |
| State/province |
Hertfordshire |
| ZIP/Postal code |
SG1 2NY |
| Country |
United Kingdom |
| |
|
| Platforms (1) |
| GPL570 |
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array |
|
| Samples (42)
|
|
| Relations |
| BioProject |
PRJNA126875 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE21935_RAW.tar |
203.2 Mb |
(http)(custom) |
TAR (of CEL) |
| Processed data included within Sample table |
|
|
|
|
 |
Less...
More...